
1331-Light-Driven Hydrogel Nanomodulators for Tumor Therapy
The research details the creation of LTG@RL, a specialized light-driven hydrogel designed to prevent cancer from returning after surgery. Scientists discovered that the fatty acid-rich environment at surgical sites causes immune cells to become suppressive, which helps residual tumor cells grow. To combat this, the hydrogel releases a nanomodulator that converts these lipids into toxic peroxides, triggering a specific cell death called ferroptosis in cancer cells. Simultaneously, the treatment uses rapamycin to reprogram immune cells, turning them into active defenders that restore the body’s…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.